NASDAQ | ETF
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
OCUL | Ocular Therapeutix Inc | Healthcare | Biotechnology | 1.62% |
ALT | Altimmune Inc | Healthcare | Biotechnology | 1.54% |
MRSN | Mersana Therapeutics Inc | Healthcare | Biotechnology | 1.32% |
FATE | Fate Therapeutics Inc | Healthcare | Biotechnology | 1.14% |
IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 1.05% |
KOD | Kodiak Sciences Inc | Healthcare | Biotechnology | 1% |
LXRX | Lexicon Pharmaceuticals Inc | Healthcare | Biotechnology | 0.94% |
ESPR | Esperion Therapeutics Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.94% |
ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 0.91% |
SIGA | SIGA Technologies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.89% |
MGNX | MacroGenics Inc | Healthcare | Biotechnology | 0.88% |
KURA | Kura Oncology Inc | Healthcare | Biotechnology | 0.88% |
HRTX | Heron Therapeuti | Healthcare | Biotechnology | 0.85% |
ARDX | Ardelyx Inc | Healthcare | Biotechnology | 0.84% |
GERN | Geron Corporation | Healthcare | Biotechnology | 0.83% |
ARVN | Arvinas Inc | Healthcare | Biotechnology | 0.82% |
KALV | Kalvista Pharmaceuticals Inc | Healthcare | Biotechnology | 0.82% |
HEAR | Turtle Beach Corp | Technology | Consumer Electronics | 0.81% |
GRTS | Gritstone Oncology Inc | Healthcare | Biotechnology | 0.8% |
INO | Inovio Pharmaceuticals Inc | Healthcare | Biotechnology | 0.79% |
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. The index excludes securities of issuers included in the Nasdaq-100 Index® (an index that measures the performance of 100 of the largest Nasdaq-listed non-financial companies by market capitalization) and the Nasdaq Next Generation 100 Index® (an index that measures the performance of the 100 largest Nasdaq-listed companies outside of the NASDAQ-100 Index® based on market capitalization). The fund is non-diversified.